Katie Ewer - Concepedia

Author

Katie Ewer

Also Known As

Adrian V S Hill, Ewer, K, Ewer, K.J., Ewer, Katie, K Ewer, K. Ewer, K. J. Ewer, Katherine R. W. Emary, Katie J. Ewer, Katie Ewer

182

Publications

24K

Citations

H-Index

Concepts

All Affiliations

University of Oxford Jenner Institute Churchill Hospital Imperial College London John Radcliffe Hospital

About

Katie Ewer is an author at University of Oxford specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	6.4K
2	Engineering	2	2	130
3	Health Sciences	1	1	140
4	Public Health	1	1	293
5	Allergy	1	1	633

Katie Ewer

Publications

20.5K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, The Lancet VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentPreliminary Report	2020	2.6K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley, The Lancet	2021	649
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Nature Medicine VaccinationVaccine DevelopmentAllergyImmunologyImmunodominance	2020	633
Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak Katie Ewer, Jonathan J Deeks, Lydia Alvarez‐Erviti, The Lancet Pulmonary TuberculosisMycobacterium Tuberculosis InfectionImmunologySchool Tuberculosis OutbreakTuberculin Skin Test	2003	623
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, reponame:Expeditio Repositorio Institucional UJTL VaccinationVaccine SafetyPhase 1/2Vaccine DevelopmentPreliminary Report	2020	536
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial Mehreen S. Datoo, Hamtandi Magloire Natama, Ousmane Traoré, The Lancet	2021	431
Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1 Tamara Berthoud, Matthew M. Hamill, Patrick Lillie, Clinical Infectious Diseases	2010	382
Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study Susan Liebeschuetz, Sheila Bamber, Katie Ewer, The Lancet Pulmonary TuberculosisSouth African ChildrenPediatric HematologyDiagnosisPediatrics	2004	367

Page 1